Targeted naltrexone for problem drinkers

Journal of Clinical Psychopharmacology

Volumn 29, Issue 4, 2009, Pages 350-357

  Kranzler, Henry R ^a,d   Tennen, Howard ^a,b   Armeli, Stephen ^c   Chan, Grace ^a   Covault, Jonathan ^a   Arias, Albert ^a   Oncken, Cheryl ^b  

^a Alcohol Research Center   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c FAIRLEIGH DICKINSON UNIVERSITY   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Alcohol pharmacotherapy; Naltrexone; Problem drinkers; Targeted medication

Indexed keywords

NALTREXONE; PLACEBO;

ADULT; AGED; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; COMBINED MODALITY THERAPY; COUNSELING; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PATIENT COMPLIANCE; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 68449083928     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181ac5213     Document Type: Article

References (23)

1. Volpicelli JR, Alterman AI, Hayashida M, et al. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876-880.
2. O'Malley S, Jaffe AJ, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 1992;49:881-887.
3. Bouza C, Angeles M, Munoz A, et al. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction. 2004;99:811-828.
4. Srisurapanont M, Jarusuraisin N. Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol. 2005;8:267-280.
5. Heinala P, Alho H, Kiianmaa K, et al. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2001;21:287-292.
6. Kranzler HR, Tennen H, Penta C, et al. Targeted naltrexone treatment of early problem drinkers. Addict Behav. 1997;22:431-436.
7. Kranzler HR, Armeli S, Tennen H, et al. Targeted naltrexone for early problem drinkers. J Clin Psychopharmacol. 2003;23:294-304.
8. Hernandez-Avila CA, Song C, Kuo L, et al. Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking. Alcohol Clin Exp Res. 2006;30:860-865.
9. Karhuvaara S, Simojoki K, Virta A, et al. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. Alcohol Clin Exp Res. 2007;31:1179-1187.
10. Sanchez-Craig M, Wilkinson DA, Davila R. Empirically based guidelines for moderate drinking: 1-year results from three studies with problem drinkers. Am J Public Health. 1995;85:823-828.
11. Babor TF, Grant M, Acuda W, et al. A randomized clinical trial of brief interventions in primary care: summary of a WHO project. Addiction. 1994;89:657-660.
12. Babor TF, Higgins-Biddle JC, Saunders J, et al. Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. 2nd ed. Publication WHO/MSD/MSB/01.6a. Geneva, Switzerland: World Health Organization; 2001.
13. Donovan DM, Kivlahan DR, Doyle SR, et al. Concurrent validity of the Alcohol Use Disorders Identification Test (AUDIT) and AUDIT zones in defining levels of severity among out-patients with alcohol dependence in the COMBINE study. Addiction. 2006;101:1696-1704.
14. First M, Spitzer R, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/PSY SCREEN). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2001.
15. Sobell L, Sobell M. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten R, Allen J, eds. Measuring Alcohol Consumption. Clifton, NJ: Humana Press; 1992.
16. Miller W, Tonigan J. The Drinker Inventory of Consequences (DrInC). NIAAA Project MATCH Monograph Series. Vol. 4. NIH Publication No. 95-3911. Bethesda, MD: National Institutes of Health; 1995.
17. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
18. Kranzler HR, Abu-Hasaballah K, Tennen H, et al. Using daily interactive voice response technology to measure drinking and related behaviors in a pharmacotherapy study. Alcohol Clin Exp Res. 2004;28:1060-1064.
19. Pettinati HM, O'Brien CP, Rabinowitz AR, et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol. 2006;26:610-625.
20. Garbutt JC, Kranzler HR, O'Malley SS, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence. JAMA. 2005;293:1617-1625.
21. Feinn R, Tennen H, Cramer J, et al. Measurement and prediction of medication compliance in problem drinkers. Alcohol Clin Exp Res. 2003;27:1286-1292.
22. Hufford MR, Shields AL, Shiftman S, et al. Reactivity to ecological momentary assessment: an example using undergraduate problem drinkers. Psychol Addict Behav. 2002;16:205-211.
23. Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295:2003-2017.